GSK-2292767
CAS No. 1254036-66-2
GSK-2292767 ( GSK2292767; GSK-2292767; GSK 2292767 )
Catalog No. M11026 CAS No. 1254036-66-2
GSK-2269557 is a highly potent and selective inhibitor of PI3Kδ (pKi=10.1).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 119 | Get Quote |
|
10MG | 189 | Get Quote |
|
25MG | 416 | Get Quote |
|
50MG | 706 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGSK-2292767
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK-2269557 is a highly potent and selective inhibitor of PI3Kδ (pKi=10.1).
-
DescriptionGSK-2269557 is a highly potent and selective inhibitor of PI3Kδ (pKi=10.1); displays >1,000 fold selectivity versus others PI3K isoforms; inhibits both IFNγ and IL-2 production in a concentration-dependent manner, with pIC50 values of 8.7 and 8.5, respectively, in a human lung parenchyma assay; shows activity in rat acute OVA model of Th2-driven lung inflammation (ED50=35 ug/kg).COPD Phase 1 Clinical
-
SynonymsGSK2292767; GSK-2292767; GSK 2292767
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorPI3Kδ
-
Research AreaInflammation/Immunology
-
IndicationCOPD
Chemical Information
-
CAS Number1254036-66-2
-
Formula Weight512.58
-
Molecular FormulaC24H28N6O5S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCS(=O)(NC1=CC(C2=CC3=C(C(C4=NC=C(CN5C[C@@H](C)O[C@@H](C)C5)O4)=C2)C=NN3)=CN=C1OC)=O
-
Chemical NameN-(5-(4-(5-(((2R,6S)-2,6-dimethylmorpholino)methyl)oxazol-2-yl)-1H-indazol-6-yl)-2-methoxypyridin-3-yl)methanesulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Down K, et al. J Med Chem. 2015 Sep 24;58(18):7381-99.
molnova catalog
related products
-
Loureirin A
Loureirin A has an inhibitory effect on platelet activation perhaps through an impairment of PI3K/Akt signaling.Loureirin A negatively affects agonist-induced platelet aggregation such as collagen collagen-related peptide (CRP) ADP and thrombin.
-
Tibolone
Tibolone is an estrogen-like compound used for the treatment of the symptoms associated with menopausal transition (i.e., climacteric symptoms) and also for the treatment of osteoporosis.
-
Seletalisib
Seletalisib (UCB-5857)is a potent, ATP-competitive, and selective PI3Kδ inhibitor with IC50 of 12 nM.